JOURNAL ARTICLES 2022, NANOMEDICINES, REVIEWS
Options to Improve the Action of PROTACs in Cancer: Development of Controlled Delivery Nanoparticles Juan A, Del Mar Noblejas-López M, Arenas-Moreira M, Alonso-Moreno C, Ocaña A. Front Cell Dev Biol. 2022 Feb 3;9:805336. PMID: 35186955; PMCID: PMC8851355 doi:...
JOURNAL ARTICLES 2022, NOVEL THERAPEUTIC AGENTS
Clinical considerations for the design of PROTACs in cancer Nieto-Jiménez C, Morafraile EC, Alonso-Moreno C, Ocaña A. Mol Cancer. 2022 Mar 7;21(1):67. PMID: 35249548; PMCID: PMC8900451. doi: 10.1186/s12943-022-01535-7...
JOURNAL ARTICLES 2022, NOVEL THERAPEUTIC AGENTS
A bis(pyrazolyl)methane derivative against clinical Staphylococcus aureus strains isolated from otitis externa Ocaña AV, Aguilera-Correa JJ, Domínguez-Jurado E, Pérez-Martínez FC, Pérez-Tanoira R, López-Carretero Y, Masiá-Mondejar J, Castro-Osma JA, Esteban J,...
JOURNAL ARTICLES 2022, NANOMEDICINES
Characterization of Tuna Gelatin-Based Hydrogels as a Matrix for Drug Delivery Hermida-Merino C, Cabaleiro D, Lugo L, Valcarcel J, Vázquez JA, Bravo I, Longo A, Salloum-Abou-Jaoude G, Solano E, Gracia-Fernández C, Piñeiro MM, Hermida-Merino D. Gels. 2022 Apr...
JOURNAL ARTICLES 2022, NANOMEDICINES
Multifunctional PLA/Gelatin Bionanocomposites for Tailored Drug Delivery Systems Moya-Lopez C, Juan A, Donizeti M, Valcarcel J, Vazquez JA, Solano E, Chapron D, Bourson P, Bravo I, Alonso-Moreno C, Clemente-Casares P, Gracia-Fernández C, Longo A, Salloum-Abou-Jaoude...
JOURNAL ARTICLES 2022, NANOMEDICINES
Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers Juan A, Noblejas-López MDM, Bravo I, Arenas-Moreira M, Blasco-Navarro C, Clemente-Casares P, Lara-Sánchez...